NIH-funded research R15 grant

Understanding how U1 snRNP proteins affect gene expression and cancer development

Official title: The role of U1 snRNP proteins in snRNP biogenesis and gene expression regulation

Funded at University of Texas Arlington · NIH-10796664 · Data updated 2026-11-12

This study is looking at how a tiny part of our cells, called U1 snRNP, helps control gene activity and how changes in it might be linked to cancer, so that we can better understand what causes tumors and potentially help patients in the future.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Arlington
NIH-funded
Lab location1 site (Arlington, United States)
Project startSeptember 7, 2023
Project endAugust 31, 2026
Funding year2023
Award (this year)$422,522
NIH project number1R15GM152936-01
Project IDNIH-10796664 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with malignancies that exhibit mutations in U1 snRNA affecting splicing.

Less likely to help

Patients without cancer or those whose conditions do not involve splicing mutations may not benefit from this research.

What this research studies

This research investigates the role of U1 small nuclear ribonucleoprotein (U1 snRNP) in the regulation of gene expression and its biogenesis. By examining how mutations in U1 snRNA affect splicing and the stability of U1 snRNP, the study aims to uncover mechanisms that may contribute to cancer development. The approach includes analyzing RNA interactions and protein assembly processes that are crucial for proper gene regulation. Patients with cancer may benefit from insights gained into how these molecular processes can lead to tumorigenesis.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for targeting cancer-related gene expression and improving treatment outcomes.

How similar studies have gone: Other research has shown promising results in understanding the role of RNA splicing in cancer, indicating that this approach has potential for success.

Where this research is happening

  • University of Texas Arlington
    Arlington, United States
    Active

Researchers

  • Principal investigator: So, Byung Ran Ranny — University of Texas Arlington
  • Study coordinator: So, Byung Ran Ranny

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.